Nonmyeloablative transplants: preclinical and clinical results.

B. Sandmaier(Fred Hutch Cancer Center), R Storb, Cong Yu(Jiangxi University of Traditional Chinese Medicine), Peter A. McSweeney(Mesoblast (United States))

PubMed

April 1, 2000

Cited by 84

Related Papers

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

|New England Journal of Medicine|2017|6k

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

|The Lancet Oncology|2018|2.3k

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

|New England Journal of Medicine|2020|1.9k

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

|Blood|2001|1.4k

Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain

|Anesthesiology|2015|838